Australis Capital logo

Australis Capital(OTC) AUSAF

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-100%
5 Year-100%
1 Year-99%
1 Month+0%
$0.00
+0.00%
+0.00Today
Australis Capital last closing stock price
MetricPriceDate
Last closeUSD 0.002026-09-22
Australis Capital stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-09-03
1 month+0%USD 0.002026-08-20
3 month+0%USD 0.002026-06-22
Year to date-99%USD 0.002025-12-31
1 year-99%USD 0.002025-09-18
3 year+0%USD 0.002023-09-21
5 year-100%USD 0.172021-09-23
Since inception-100%USD 1.992018-09-28

Australis Capital Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$6.37M

Net Income (TTM)

-CA$18.40M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-59147.33 (Low)

Price

$0.00

Volume

50

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Sep 10, 2024

AUSAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Australis Capital

Australis Capital Inc. is a cannabis enterprise engaged in diverse cannabis and horticultural ventures across multiple international markets. The company operates in regions including the United States, Canada, and various countries in Europe and Asia, positioning itself as a significant player in the global cannabis industry.

Products and Services
  • Focus on cannabis cultivation and distribution
  • Investment in horticultural technology and innovation
  • Development of international cannabis markets
Growth Outlook
  • Expanding operations in emerging cannabis markets globally
  • Strategic partnerships to enhance market reach and capabilities
  • Potential for increased revenue as legalization trends continue
Financial Highlights
  • Recent quarterly revenue of CAD 3,103,117, showing growth potential
  • Trailing twelve months gross profit margin at 52.39%, indicating operational efficiency
  • Current ratio of 0.69, reflecting liquidity position
Australis Capital Inc. is positioned in the rapidly evolving cannabis sector, with a focus on both cultivation and technological advancements. The company's international footprint allows it to tap into various markets, which is crucial as global attitudes toward cannabis continue to shift. Recent financial data indicates a revenue increase, suggesting that the company is on a growth trajectory. The gross profit margin reflects a solid operational foundation, while the current ratio indicates a manageable liquidity position. As the cannabis industry matures, Australis Capital Inc. may benefit from increased demand and market expansion, making it an intriguing option for investors interested in the sector.
AI Generated • Sep 22, 2026

Industry

Pharmaceuticals

CEO

Terry Booth

Headquarters

Las Vegas, NV 89119, US

AUSAF Financials

Key Financial Metrics (TTM)

Gross Margin

52.39%

Operating Margin

-255.97%

Net Income Margin

-661.50%

Return on Equity

-143.69%

Return on Capital

-82.85%

Return on Assets

-98.98%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

50

Avg. Volume

894.5

Financials (TTM)

Gross Profit

CA$4.14M

Operating Income

-CA$12.15M

EBITDA

-CA$23.80M

Operating Cash Flow

-CA$8.80M

Capital Expenditure

-CA$134.89K

Free Cash Flow

-CA$8.94M

Cash & ST Invst.

CA$727.69

Total Debt

CA$0.00

Australis Capital Performance Analysis

Australis Capital annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-03-31CAD 7,556,203N/A
Australis Capital sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12021-06-30376230.4%
Q22021-09-3031.5%
Q32021-12-314.4%
Q42022-03-31-99.9%
Australis Capital annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-03-31CAD -0.16N/A
Australis Capital sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12021-06-30-335.8%
Q22021-09-3057.4%
Q32021-12-31-9.8%
Q42022-03-31-528.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q4 2021YOY CHG

Revenue

CA$3.10K

+575.8%

Gross Profit

CA$1.73K

+7200.4%

Gross Margin

55.67%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

18

N/A

Net Income

-CA$31.72K

-101.0%

EBITDA

-CA$6.70M

-317.8%

Quarterly Fundamentals

Name
Q4 2021YOY CHG

Total Cash

CA$727.69

-82.6%

Total Debt

CA$0.00

N/A

Accounts Receivable

CA$3.55M

+112.7%

Inventory

CA$0.00

-100.0%

Long Term Debt

CA$2.45K

-99.8%

Short Term Debt

CA$0.00

-100.0%

Return on Assets

-98.98%

N/A

Return on Invested Capital

-48.49%

N/A

Free Cash Flow

-CA$5.34K

-228.6%

Operating Cash Flow

-CA$5.37K

-309.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IONKFIonic Brands Corp.
$0.00+0.00%
CBIHCannabis Bioscience International Holdings, Inc.
$0.00+0.00%
LOBEFLobe Sciences Ltd.
$0.05+0.00%
TWSITristar Wellness Solutions Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
GLNDGreenland Energy
$5.54+3.55%
INTCIntel
$123.00-3.45%
NVDANvidia
$225.07+0.22%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.94-3.02%

Questions About AUSAF

What is the current price of Australis Capital?

Australis Capital is trading at $0.00 per share.

What is the 52-week range for Australis Capital?

Over the past 52 weeks, Australis Capital has traded between $0.00 and $0.00.

How much debt does Australis Capital have?

Australis Capital total debt is unavailable.

How much cash does Australis Capital have on hand?

Australis Capital reported CA$582.60K in cash and cash equivalents in its most recent financial results.

What is Australis Capital’s dividend yield?

Australis Capital does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.